Cancer Researchers Use Platform LSF in Genomics Research
TORONTO, Canada, Nov. 30 — Platform Computing, today announced that Cancer Research UK, a world leader in the study of cancer, has turned to Platform LSF to help drive forward its human genome research project at the Cambridge Research Institute (CRI). Platform LSF is the most powerful workload manager available for high performance computing (HPC) environments and scientific computing. By integrating Platform LSF with a new advanced genetic sequencing platform, the institute has gained greater insight into genetic cancer mutations, that will lead to scientific breakthroughs in the areas of cancer diagnosis, treatment and prevention.
